×

Methods and compositions for treating thyroid-related medical conditions with reduced folates

  • US 9,248,130 B2
  • Filed: 10/01/2013
  • Issued: 02/02/2016
  • Est. Priority Date: 07/10/2009
  • Status: Active Grant
First Claim
Patent Images

1. A composition, comprising:

  • (a) a drug, agent, or medication that acts as a replacement for a hormone that is normally produced by the thyroid gland selected from the group consisting of levothyroxine, levothyroxine sodium, liothyronine sodium, liotrix, thyroxine and triiodothyronine, and (b) a reduced folate selected from the group consisting of 5-methyltetrahydrofolic acid and 6(S)-5-methyltetrahydrofolate.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×